The companies noted that, at 48 weeks, the novel investigational combination maintained a high rate (n=49; 94.2%) of viral ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

Alchemy, a developer of in-house pharmacy programs for clinics with large HIV and hepatitis C patient populations, raised $31 ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data focused ...

To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...

A man who identified himself as an HIV/AIDS advocate complained about the bad treatment they received from healthcare workers. “When we get there late, we are shouted at and they told that we ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade ...

Lenacapavir is an important medication for HIV prevention and treatment. The agreement aims to bolster access to lenacapavir in 120 countries, with a particular focus on resource-limited nations that ...

Lenacapavir is approved by US FDA for infection caused by the human immunodeficiency virus (HIV) for heavily treatment-experienced patients (HTE), and is being investigated for use in HIV prevention.

Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town A new drug to prevent HIV infection ...

Dr. Reddy’s has been granted a non-exclusive voluntary licence to manufacture Lenacapavir and market it in 120 countries, for the current approved indication of HIV treatment in heavily ...